» Authors » Marian C Clahsen-van Groningen

Marian C Clahsen-van Groningen

Explore the profile of Marian C Clahsen-van Groningen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 85
Citations 1010
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fang Y, Nikolaev A, Essers J, Ambagtsheer G, Clahsen-van Groningen M, Minnee R, et al.
Artif Organs . 2025 Mar; PMID: 40071314
Objectives: Marginal donor kidneys are increasingly used for transplantation to overcome organ shortage. This study aims to investigate the additional value of Power Doppler (PD) imaging in kidney quality assessment...
2.
Fang Y, Ambagtsheer G, Xia L, Clahsen-van Groningen M, Minnee R, de Bruin R
Heliyon . 2025 Jan; 11(2):e41610. PMID: 39877618
Background: Normothermic machine perfusion (NMP) provides a platform for kidney quality assessment. Donation after circulatory death (DCD) donor kidneys are associated with great ischemic injury and high intrarenal resistance (IRR)....
3.
Varol H, Wagenmakers A, Hoeft K, Callemeyn J, Bodewes R, Bramer W, et al.
Transpl Int . 2025 Jan; 37():13464. PMID: 39834692
Microvascular inflammation (MVI) in kidney transplant biopsies is mainly associated with antibody-mediated rejection (AMR), sparking debate within the Banff Classification of Renal Allograft Pathology regarding its exclusivity. This study reviewed...
4.
Hoeft K, Bleckwehl T, Schumacher D, Kim H, Meyer R, Long Q, et al.
Nat Commun . 2024 Dec; 15(1):10612. PMID: 39638798
Single cell RNA sequencing has provided unprecedented insights into the molecular cues and cellular heterogeneity underlying human disease. However, the high costs and complexity of single cell methods remain a...
5.
van Vugt L, Tegzess E, van der Zwan M, Clahsen-van Groningen M, de Winter B, Vart P, et al.
Clin Transplant . 2024 Dec; 38(12):e70046. PMID: 39636744
Background: Alemtuzumab can be an alternative to rabbit anti-thymocyte globulin (rATG) to treat severe or glucocorticoid-resistant acute T cell-mediated kidney transplant rejection (TCMR). Yet, there are few reports in which...
6.
de Weerd A, Roelen D, Betjes M, Clahsen-van Groningen M, Haasnoot G, Kho M, et al.
Transplant Direct . 2024 Sep; 10(9):e1695. PMID: 39220218
Background: In HLA-incompatible kidney transplantation, the efficacy of desensitization in terms of anti-HLA antibody kinetics is not well characterized. We present an overview of the course of anti-HLA antibodies throughout...
7.
van Baardwijk M, Wagenmakers A, van den Bosch T, Hesselink D, Loupy A, Kramann R, et al.
Nephrol Dial Transplant . 2024 Aug; 40(2):224-226. PMID: 39215437
No abstract available.
8.
Shankar A, Tejeda-Mora H, Du Z, Nlandu Q, Palomares-Cabeza V, van den Bosch T, et al.
Transpl Int . 2024 May; 37:12468. PMID: 38699175
Kidney organoids are an innovative tool in transplantation research. The aim of the present study was to investigate whether kidney organoids are susceptible for allo-immune attack and whether they can...
9.
Nikolaev A, Fang Y, Essers J, Panth K, Ambagtsheer G, Clahsen-van Groningen M, et al.
Photoacoustics . 2024 Feb; 36:100596. PMID: 38379853
Due to the shortage of kidneys donated for transplantation, surgeons are forced to use the organs with an elevated risk of poor function or even failure. Although the existing methods...
10.
Cristoferi I, Varol H, van Baardwijk M, Rahiem L, Lila K, van den Bosch T, et al.
Kidney Int . 2023 Dec; 105(4):812-823. PMID: 38128610
Kidney transplant (KTx) biopsies showing transplant glomerulopathy (TG) (glomerular basement membrane double contours (cg) > 0) and microvascular inflammation (MVI) in the absence of C4d staining and donor-specific antibodies (DSAs)...